Protein detail

ADA2C

Alpha-2C adrenergic receptor (Alpha-2 adrenergic receptor subtype C4) (Alpha-2C adrenoreceptor) (Alpha-2C adrenoceptor) (Alpha-2CAR)

Protein symbol
ADA2C
UniProt ID
EVMP score
0.25
Frequency
2
Transmembrane count
7
Protein classification
FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins
Basic Information
Protein Names
Alpha-2C adrenergic receptor (Alpha-2 adrenergic receptor subtype C4) (Alpha-2C adrenoreceptor) (Alpha-2C adrenoceptor) (Alpha-2CAR)
Protein Class
FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins
Protein Function
  • FDA approved drug targets:Small molecule drugs
  • G-protein coupled receptors:GPCRs excl olfactory receptors
Transmembrane
49..74; Helical; Name=1; 88..110; Helical; Name=2; 122..147; Helical; Name=3; 168..187; Helical; Name=4; 209..231; Helical; Name=5; 384..408; Helical; Name=6; 417..440; Helical; Name=7
Transmembrane Count
7
Entrez Gene Symbol
Gene Synonym
ADRA2L2ADRA2RL2ADRARL2
Gene Description
Adrenoceptor alpha 2C
Chromosome
4
Position
3766348-3768526
Frequency
2
EVMP Score
0.25
Fluorescence & Localization
Tissue Specificbone marrowCell SpecificMonocyte progenitors
Function & Pathway
Protein Function
  • FDA approved drug targets:Small molecule drugs
  • G-protein coupled receptors:GPCRs excl olfactory receptors
Canonical Pathways
  • M33 Pid glypican 1pathway
  • M252 Pid il8 cxcr1 pathway
  • M76 Pid p38 alpha beta pathway
Mediation Categories
Clinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation
Relations & Evidence

Enzyme-Mediated Modification

0 records.

Ligand-Receptor Signaling

46 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
intracellularintracellularComPPINoNoNoYesNo
intracellularintracellularGO_IntercellNoNoNoYesNo
intracellularintracellularOmniPathNoNoNoYesNo
transmembranetransmembraneUniProt_locationNoNoNoYesNo
transmembranetransmembraneUniProt_topologyNoNoNoYesNo
transmembranetransmembraneUniProt_keywordNoNoNoYesNo
transmembranetransmembraneGO_IntercellNoNoNoYesNo
transmembranetransmembraneCellPhoneDBNoNoNoYesNo
transmembranetransmembraneTopDBNoNoNoYesNo
transmembranetransmembraneLOCATENoNoNoYesNo
Page 3 of 5PreviousNext

Regulatory Interaction Network

4 records.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
ADA2CP18825GNAZP19086YesYesNoSIGNORSIGNOR:31160049
ADA2CP18825GNAI3P08754YesYesNoSIGNORSIGNOR:31160049
ADA2CP18825GNAI1P63096YesYesNoSIGNORSIGNOR:31160049
ADA2CP18825GNAOP09471YesYesNoHPRDSIGNORHPRD:1349607SIGNOR:31160049

Protein Complex Composition

1 record.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
ADRA2CP188252PDBPDB:6kuw

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Mass spectrometry0
Sequence, Structure & Domains

Sequences

Length
462
Mass
49,522
Sequence
MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ

3D Structural Models

Helix
48..78; 80..82; 85..87; 88..103; 105..114; 120..154; 156..160; 165..183; 208..218; 220..239; 372..408; 409..412; 416..428; 429..431; 433..440; 442..452
3D Structure
X-ray crystallography (1)

Domain & Motif Annotations

Compositional Bias
294..308; Basic residues; 311..325; Gly residues
Region
246..347; Disordered
Protein Families
  • G-protein coupled receptor 1 family
  • Adrenergic receptor subfamily
  • ADRA2C sub-subfamily
Sequence Similarities
Belongs to the G-protein coupled receptor 1 family. Adrenergic receptor subfamily. ADRA2C sub-subfamily.
Clinical Relevance
Disease Involvement
FDA approved drug targets
Biomarker
Discontinued in Phase 2; Phase 2; Terminated; Phase 3; Preclinical; Investigative; Discontinued in Phase 3; Approved; Discontinued in Preregistration; Phase 4
Drug Targets
FDA approved drug targets
Antibody